
Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
Description
About Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
The Human HLA class II antigen , DR alpha chain Peptide (IEDB: 4397) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The HLA class II antigen Peptide, H-ASFEAQGALANIAVDKA-OH (Uniprot: P01903 aa: 77-93) from JPT is produced under strict quality control and quality management.
Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA - Specifications
- Peptide sequence: H-ASFEAQGALANIAVDKA-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- CAS: 137756-45-7
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Prediabetes
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
References:
Read References with JPT’s Antigen Peptides
Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA has been described in:
IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule., J Immunol, 2001 (PMID: 11564833)
Prevention of murine lupus by an I-E alpha chain transgene: protective role of I-E alpha chain-derived peptides with a high affinity to I-Ab molecules., Eur J Immunol, 1996 (PMID: 8617296)
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis., J Exp Med, 1995 (PMID: 7532675)
Documentation
Documentation for Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
Properties
Properties of Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Prediabetes |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | HLA class II antigen |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human HLA class II, DR alpha chain 77-93, ASFEAQGALANIAVDKA
Information | Values |
---|---|
Sequence: | H-ASFEAQGALANIAVDKA-OH |
Specifications: | 17mer peptide as TFA salt |